{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T04:17:55Z","timestamp":1778818675328,"version":"3.51.4"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2022,11,28]],"date-time":"2022-11-28T00:00:00Z","timestamp":1669593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,11,28]],"date-time":"2022-11-28T00:00:00Z","timestamp":1669593600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Cardiol Rep"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1007\/s11886-022-01801-6","type":"journal-article","created":{"date-parts":[[2022,11,28]],"date-time":"2022-11-28T10:02:12Z","timestamp":1669629732000},"page":"2031-2041","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["COVID-19 Vaccine\u2013Related Myocardial and Pericardial Inflammation"],"prefix":"10.1007","volume":"24","author":[{"given":"Muhammad","family":"Furqan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanchit","family":"Chawla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad","family":"Majid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samia","family":"Mazumdar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gauranga","family":"Mahalwar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evan","family":"Harmon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9240-8369","authenticated-orcid":false,"given":"Allan","family":"Klein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,11,28]]},"reference":[{"key":"#cr-split#-1801_CR1.1","doi-asserted-by":"crossref","unstructured":"Tsch\u00f6pe C, Ammirati E, Bozkurt B, Caforio ALP, Cooper LT, Felix SB, et al. Myocarditis and inflammatory cardiomyopathy: current evidence and future directions. Nat Rev Cardiol. 2020 183 [Internet]. Nature Publishing Group","DOI":"10.1038\/s41569-020-00435-x"},{"key":"#cr-split#-1801_CR1.2","unstructured":"2020 [cited 2022 Aug 29];18:169-93. Available from: https:\/\/www.nature.com\/articles\/s41569-020-00435-x."},{"key":"1801_CR2","doi-asserted-by":"crossref","unstructured":"Fairweather DL, Cooper LT, Blauwet LA. Sex and gender differences in myocarditis and dilated cardiomyopathy. Curr Probl Cardiol [Internet]. Curr Probl Cardiol. 2013 [cited 2022 Aug 29];38:7\u201346. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/23158412\/.","DOI":"10.1016\/j.cpcardiol.2012.07.003"},{"key":"1801_CR3","doi-asserted-by":"crossref","unstructured":"Prepoudis A, Koechlin L, Nestelberger T, Boeddinghaus J, Lopez-Ayala P, Wussler D, et al. Incidence, clinical presentation, management, and outcome of acute pericarditis and myopericarditis. Eur Hear Journal Acute Cardiovasc Care [Internet]. Oxford Academic; 2022 [cited 2022 Aug 29];11:137\u201347. Available from: https:\/\/academic.oup.com\/ehjacc\/article\/11\/2\/137\/6445206.","DOI":"10.1093\/ehjacc\/zuab108"},{"key":"1801_CR4","unstructured":"Lota AS, Halliday B, Tayal U, Salmi S, Shakur R, Hammersley D, et al. Epidemiological trends and outcomes of acute myocarditis in the National Health Service of England | Circulation. AHA [Internet]. 2019 [cited 2022 Sep 2];140. Available from: https:\/\/www.ahajournals.org\/doi\/10.1161\/circ.140.suppl_1.11463."},{"key":"1801_CR5","doi-asserted-by":"crossref","unstructured":"Su JR, McNeil MM, Welsh KJ, Marquez PL, Ng C, Yan M, et al. Myopericarditis after vaccination, Vaccine Adverse Event Reporting System (VAERS), 1990\u20132018. Vaccine [Internet]. Vaccine. 2021 [cited 2022 Aug 29];39:839\u201345. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/33422381\/.","DOI":"10.1016\/j.vaccine.2020.12.046"},{"key":"1801_CR6","doi-asserted-by":"crossref","unstructured":"Polack FP, Thomas SJ, Kitchin N, Absalon J, Gurtman A, Lockhart S, et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med [Internet]. Massachusetts Medical Society; 2020 [cited 2022 Aug 29];383:2603\u201315. Available from: https:\/\/www.nejm.org\/doi\/full\/10.1056\/nejmoa2034577.","DOI":"10.1056\/NEJMoa2034577"},{"key":"1801_CR7","doi-asserted-by":"crossref","unstructured":"Baden LR, El Sahly HM, Essink B, Kotloff K, Frey S, Novak R, et al. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N Engl J Med [Internet]. Massachusetts Medical Society; 2021 [cited 2022 Sep 2];384:403\u201316. Available from: https:\/\/www.nejm.org\/doi\/full\/10.1056\/nejmoa2035389.","DOI":"10.1056\/NEJMoa2035389"},{"key":"1801_CR8","doi-asserted-by":"crossref","unstructured":"Bozkurt B, Kamat I, Hotez PJ. Myocarditis with COVID-19 mRNA vaccines. Circulation [Internet]. Lippincott Williams & WilkinsHagerstown, MD; 2021 [cited 2022 Aug 29];144:471\u201384. Available from: https:\/\/www.ahajournals.org\/doi\/abs\/10.1161\/CIRCULATIONAHA.121.056135.","DOI":"10.1161\/CIRCULATIONAHA.121.056135"},{"key":"1801_CR9","doi-asserted-by":"crossref","unstructured":"Gubernot D, Jazwa A, Niu M, Baumblatt J, Gee J, Moro P, et al. U.S. population-based background incidence rates of medical conditions for use in safety assessment of COVID-19 vaccines. Vaccine [Internet]. Vaccine. 2021 [cited 2022 Aug 29];39:3666\u201377. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/34088506\/.","DOI":"10.1016\/j.vaccine.2021.05.016"},{"key":"1801_CR10","doi-asserted-by":"crossref","unstructured":"Oster ME, Shay DK, Su JR, Gee J, Creech CB, Broder KR, et al. Myocarditis cases reported after mRNA-based COVID-19 vaccination in the US from December 2020 to August 2021. JAMA [Internet]. American Medical Association; 2022 [cited 2022 Aug 29];327:331\u201340. Available from: https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2788346.","DOI":"10.1001\/jama.2022.5134"},{"key":"1801_CR11","doi-asserted-by":"crossref","unstructured":"Shimabukuro TT, Nguyen M, Martin D, DeStefano F. Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS). Vaccine [Internet]. NIH Public Access; 2015 [cited 2022 Aug 29];33:4398. Available from:\u00a0https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC4632204\/.","DOI":"10.1016\/j.vaccine.2015.07.035"},{"key":"1801_CR12","doi-asserted-by":"crossref","unstructured":"Witberg G, Barda N, Hoss S, Richter I, Wiessman M, Aviv Y, et al. Myocarditis after Covid-19 vaccination in a large health care organization. N Engl J Med [Internet]. Massachusetts Medical Society; 2021 [cited 2022 Aug 29];385:2132\u20139. Available from: https:\/\/www.nejm.org\/doi\/10.1056\/NEJMoa2110737.","DOI":"10.1056\/NEJMoa2110737"},{"key":"1801_CR13","doi-asserted-by":"crossref","unstructured":"Husby A, Hansen JV, Fosb\u00f8l E, Thiesson EM, Madsen M, Thomsen RW, et al. SARS-CoV-2 vaccination and myocarditis or myopericarditis: population based cohort study. BMJ. BMJ Publishing Group; 2021;375.","DOI":"10.1136\/bmj-2021-068665"},{"key":"1801_CR14","doi-asserted-by":"crossref","unstructured":"Patone M, Mei XW, Handunnetthi L, Dixon S, Zaccardi F, Shankar-Hari M, et al. Risk of myocarditis after sequential doses of COVID-19 vaccine and SARS-CoV-2 infection by age and sex. Circulation [Internet]. Lippincott Williams & Wilkins Hagerstown, MD ; 2022 [cited 2022 Aug 29]; Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/35993236.","DOI":"10.1161\/CIRCULATIONAHA.122.059970"},{"key":"1801_CR15","doi-asserted-by":"crossref","unstructured":"Chua GT, Kwan MYW, Chui CSL, Smith RD, Cheung EC-L, Ma T, et al. Epidemiology of acute myocarditis\/pericarditis in Hong Kong adolescents following comirnaty vaccination. Clin Infect Dis. Oxford University Press (OUP); 2021.","DOI":"10.1093\/cid\/ciab989"},{"key":"1801_CR16","doi-asserted-by":"crossref","unstructured":"Mascellino MT, Di Timoteo F, De Angelis M, Oliva A. Overview of the main anti-SARS-CoV-2 vaccines: mechanism of action, efficacy and safety. Infect Drug Resist [Internet]. Dove Press; 2021 [cited 2022 Sep 30];14:3459. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC8418359\/.","DOI":"10.2147\/IDR.S315727"},{"key":"1801_CR17","doi-asserted-by":"crossref","unstructured":"Cox RJ, Brokstad KA. Not just antibodies: B cells and T cells mediate immunity to COVID-19. Nat Rev Immunol 2020 2010 [Internet]. Nature Publishing Group; 2020 [cited 2022 Sep 30];20:581\u20132. Available from: https:\/\/www.nature.com\/articles\/s41577-020-00436-4.","DOI":"10.1038\/s41577-020-00436-4"},{"key":"1801_CR18","doi-asserted-by":"crossref","unstructured":"Cox RJ, Brokstad KA. Not just antibodies: B cells and T cells mediate immunity to COVID-19. Nat Rev Immunol 2020 2010 [Internet]. Nature Publishing Group; 2020 [cited 2022 Aug 29];20:581\u20132. Available from: https:\/\/www.nature.com\/articles\/s41577-020-00436-4.","DOI":"10.1038\/s41577-020-00436-4"},{"key":"1801_CR19","doi-asserted-by":"crossref","unstructured":"Sette A, Crotty S. Adaptive immunity to SARS-CoV-2 and COVID-19. Cell [Internet]. Elsevier; 2021 [cited 2022 Aug 29];184:861. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC7803150\/.","DOI":"10.1016\/j.cell.2021.01.007"},{"key":"1801_CR20","doi-asserted-by":"crossref","unstructured":"Shah S, Danda D, Kavadichanda C, Das S, Adarsh MB, Negi VS. Autoimmune and rheumatic musculoskeletal diseases as a consequence of SARS-CoV-2 infection and its treatment. Rheumatol Int [Internet]. Springer; 2020 [cited 2022 Sep 19];40:1539\u201354. Available from: https:\/\/link.springer.com\/article\/10.1007\/s00296-020-04639-9.","DOI":"10.1007\/s00296-020-04639-9"},{"key":"1801_CR21","doi-asserted-by":"publisher","unstructured":"Kim JY, Ko JH, Kim Y, Kim YJ, Kim JM, Chung YS, et al. Viral load kinetics of SARS-CoV-2 infection in first two patients in Korea. J Korean Med Sci [Internet]. Korean Academy of Medical Science; 2019 [cited 2022 Sep 19];35. https:\/\/doi.org\/10.3346\/jkms.2020.35.e86.","DOI":"10.3346\/jkms.2020.35.e86"},{"key":"1801_CR22","doi-asserted-by":"crossref","unstructured":"Ehrenfeld M, Tincani A, Andreoli L, Cattalini M, Greenbaum A, Kanduc D, et al. Covid-19 and autoimmunity. Autoimmun Rev [Internet]. Elsevier; 2020 [cited 2022 Sep 19];19:102597. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC7289100\/.","DOI":"10.1016\/j.autrev.2020.102597"},{"key":"1801_CR23","doi-asserted-by":"crossref","unstructured":"Neidleman J, Luo X, McGregor M, Xie G, Murray V, Greene WC, et al. Mrna vaccine-induced t cells respond identically to sars-cov-2 variants of concern but differ in longevity and homing properties depending on prior infection status. Elife. eLife Sciences Publications Ltd; 2021;10.","DOI":"10.7554\/eLife.72619"},{"key":"1801_CR24","doi-asserted-by":"crossref","unstructured":"Murphy WJ, Longo DL. A possible role for anti-idiotype antibodies in SARS-CoV-2 infection and vaccination. N Engl J Med [Internet]. Massachusetts Medical Society; 2022 [cited 2022 Sep 19];386:394\u20136. Available from: https:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMcibr2113694.","DOI":"10.1056\/NEJMcibr2113694"},{"key":"1801_CR25","doi-asserted-by":"crossref","unstructured":"Paque RE, Miller R. Autoanti-idiotypes exhibit mimicry of myocyte antigens in virus-induced myocarditis. J Virol [Internet]. American Society for Microbiology (ASM); 1991 [cited 2022 Sep 19];65:16. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC240484\/?report=abstract.","DOI":"10.1128\/jvi.65.1.16-22.1991"},{"key":"1801_CR26","doi-asserted-by":"crossref","unstructured":"Huber SA, Pfaeffle B. Differential Th1 and Th2 cell responses in male and female BALB\/c mice infected with coxsackievirus group B type 3. J Virol [Internet]. J Virol; 1994 [cited 2022 Aug 29];68:5126\u201332. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/8035512\/.","DOI":"10.1128\/jvi.68.8.5126-5132.1994"},{"key":"1801_CR27","doi-asserted-by":"crossref","unstructured":"Kyt\u00f6 V, Sipil\u00e4 J, Rautava P. Clinical profile and influences on outcomes in patients hospitalized for acute pericarditis. Circulation [Internet]. Lippincott Williams and Wilkins; 2014 [cited 2021 Feb 2];130:1601\u20136. Available from: https:\/\/www.ahajournals.org\/doi\/10.1161\/CIRCULATIONAHA.114.010376.","DOI":"10.1161\/CIRCULATIONAHA.114.010376"},{"key":"1801_CR28","doi-asserted-by":"crossref","unstructured":"Ammirati E, Cipriani M, Moro C, Raineri C, Pini D, Sormani P, et al. Clinical presentation and outcome in a contemporary cohort of patients with acute myocarditis: multicenter Lombardy Registry. Circulation [Internet]. Circulation; 2018 [cited 2022 Aug 29];138:1088\u201399. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/29764898\/.","DOI":"10.1161\/CIRCULATIONAHA.118.035319"},{"key":"1801_CR29","doi-asserted-by":"crossref","unstructured":"Kociol RD, Cooper LT, Fang JC, Moslehi JJ, Pang PS, Sabe MA, et al. Recognition and initial management of fulminant myocarditis. Circulation [Internet]. Lippincott Williams & WilkinsHagerstown, MD; 2020 [cited 2022 Aug 29];141:E69\u201392. Available from: https:\/\/www.ahajournals.org\/doi\/abs\/10.1161\/CIR.0000000000000745.","DOI":"10.1161\/CIR.0000000000000745"},{"key":"1801_CR30","doi-asserted-by":"crossref","unstructured":"Corrado D, Basso C, Thiene G. Sudden cardiac death in young people with apparently normal heart. Cardiovasc Res [Internet]. Cardiovasc Res; 2001 [cited 2022 Aug 29];50:399\u2013408. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/11334844\/.","DOI":"10.1016\/S0008-6363(01)00254-1"},{"key":"1801_CR31","doi-asserted-by":"crossref","unstructured":"Cooper LT, Baughman KL, Feldman AM, Frustaci A, Jessup M, Kuhl U, et al. The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology. Circulation [Internet]. Circulation; 2007 [cited 2022 Aug 29];116:2216\u201333. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/17959655\/.","DOI":"10.1161\/CIRCULATIONAHA.107.186093"},{"key":"1801_CR32","doi-asserted-by":"crossref","unstructured":"Adler Y, Charron P, Imazio M, Badano L, Bar\u00f3n-Esquivias G, Bogaert J, et al. 2015 ESC Guidelines for the diagnosis and management of pericardial diseases. Eur. Heart J. Oxford University Press; 2015. p. 2921\u201364.","DOI":"10.1016\/j.rec.2015.10.008"},{"key":"1801_CR33","doi-asserted-by":"crossref","unstructured":"Ambati S, Colon M, Mihic M, Sanchez J, Bakar A. Acute myopericarditis after COVID-19 vaccine in teenagers. Case reports Cardiol [Internet]. Case Rep Cardiol; 2021 [cited 2022 Aug 29];2021:1\u20135. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/34589238\/.","DOI":"10.1155\/2021\/8268755"},{"key":"1801_CR34","doi-asserted-by":"crossref","unstructured":"Fleming-Nouri A, Haimovich AD, Yang D, Schulz WL, Coppi A, Taylor RA. Myopericarditis in young adults presenting to the emergency department after receiving a second COVID\u201019 mRNA vaccine. Acad Emerg Med [Internet]. Wiley-Blackwell; 2021 [cited 2022 Aug 29];28:802. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC8441914\/","DOI":"10.1111\/acem.14307"},{"key":"1801_CR35","doi-asserted-by":"crossref","unstructured":"Sakaguchi S, Fujimoto N, Ichikawa K, Izumi D, Katsuta K, Takafuji M, et al. Myopericarditis after COVID-19 mRNA vaccination. Circ J [Internet]. Circ J; 2022 [cited 2022 Aug 29];86:472. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/34588400\/.","DOI":"10.1253\/circj.CJ-21-0683"},{"key":"1801_CR36","doi-asserted-by":"crossref","unstructured":"Chen DH, Arefin AR, Joshi A, Khanji MY. Myopericarditis in a teenager following first mRNA COVID vaccine dose: the role of multi-parametric cardiovascular magnetic resonance. Eur Hear J Case Reports [Internet]. Oxford University Press; 2021 [cited 2022 Aug 29];5. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC8493007\/.","DOI":"10.1093\/ehjcr\/ytab371"},{"key":"#cr-split#-1801_CR37.1","unstructured":"Das BB, Kohli U, Ramachandran P, Nguyen HH, Greil G, Hussain T, et al. Myopericarditis after messenger RNA coronavirus disease 2019 vaccination in adolescents 12 to 18\u00a0years of age. J Pediatr [Internet]. Elsevier Inc."},{"key":"#cr-split#-1801_CR37.2","unstructured":"2021 [cited 2022 Aug 29];238:26-32.e1. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC8321962."},{"key":"1801_CR38","doi-asserted-by":"crossref","unstructured":"Nygaard U, Holm M, Bohnstedt C, Chai Q, Schmidt LS, Hartling UB, et al. Population-based incidence of myopericarditis after COVID-19 vaccination in Danish adolescents. Pediatr Infect Dis J [Internet]. Pediatr Infect Dis J; 2022 [cited 2022 Aug 29];41:E25\u20138. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/34889875\/.","DOI":"10.1097\/INF.0000000000003389"},{"key":"1801_CR39","doi-asserted-by":"crossref","unstructured":"Bartlett VL, Thomas A, Hur DJ, Malm B. Myopericarditis with significant left ventricular dysfunction following COVID-19 vaccination: a case report. Am J Case Rep [Internet]. Am J Case Rep; 2021 [cited 2022 Aug 29];22. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/34795198\/.","DOI":"10.12659\/AJCR.934066"},{"key":"1801_CR40","doi-asserted-by":"crossref","unstructured":"Badshah M, Shriver J, Rynders B, Sjovold A, Shaukat MHS, Rajpurohit N. MODERNA mRNA-1273 vaccine-associated myopericarditis in a patient with a subclinical autoimmune predisposition. J Cardiol Cases [Internet]. Japanese College of Cardiology; 2021 [cited 2022 Aug 29];24:227. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC8617476\/.","DOI":"10.1016\/j.jccase.2021.09.007"},{"key":"1801_CR41","doi-asserted-by":"crossref","unstructured":"Hung YP, Sun KS. A case of myopericarditis with pleuritis following AstraZeneca Covid-19 vaccination. QJM [Internet]. QJM; 2022 [cited 2022 Aug 29];114:879\u201381. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/34741522\/.","DOI":"10.1093\/qjmed\/hcab278"},{"key":"1801_CR42","doi-asserted-by":"crossref","unstructured":"McLean K, Johnson TJ. Myopericarditis in a previously healthy adolescent male following COVID-19 vaccination: a case report. Acad Emerg Med [Internet]. Acad Emerg Med; 2021 [cited 2022 Aug 29];28:918\u201321. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/34133825\/.","DOI":"10.1111\/acem.14322"},{"key":"1801_CR43","doi-asserted-by":"crossref","unstructured":"Schauer J, Buddhe S, Colyer J, Sagiv E, Law Y, Mallenahalli Chikkabyrappa S, et al. Myopericarditis after the Pfizer messenger ribonucleic acid coronavirus disease vaccine in adolescents. J Pediatr [Internet]. Elsevier; 2021 [cited 2022 Aug 29];238:317. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC8253718\/.","DOI":"10.1016\/j.jpeds.2021.06.083"},{"key":"1801_CR44","doi-asserted-by":"crossref","unstructured":"Farooq M, Mohammed Y, Zafar M, Dharmasena D, Rana UI, Kankam O. COVID-19 vaccine-induced pneumonitis, myositis and myopericarditis. Cureus [Internet]. Cureus; 2022 [cited 2022 Aug 29];14. Available from: https:\/\/www.cureus.com\/articles\/82331-covid-19-vaccine-induced-pneumonitis-myositis-and-myopericarditis.","DOI":"10.7759\/cureus.20979"},{"key":"1801_CR45","doi-asserted-by":"crossref","unstructured":"Umei TC, Kishino Y, Watanabe K, Shiraishi Y, Inohara T, Yuasa S, et al. Recurrence of myopericarditis following mRNA COVID-19 vaccination in a male adolescent. CJC open [Internet]. CJC Open; 2022 [cited 2022 Aug 29];4:350\u20132. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/34904134\/.","DOI":"10.1016\/j.cjco.2021.12.002"},{"key":"1801_CR46","doi-asserted-by":"crossref","unstructured":"Kim D, Choi JH, Jang JY, So O, Cho EJ, Choi H, et al. A case report for myopericarditis after BNT162b2 COVID-19 mRNA vaccination in a Korean young male. J Korean Med Sci [Internet]. J Korean Med Sci; 2021 [cited 2022 Aug 29];36:1\u20137. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/34636504\/.","DOI":"10.3346\/jkms.2021.36.e277"},{"key":"1801_CR47","doi-asserted-by":"crossref","unstructured":"Ameratunga R, Woon ST, Sheppard MN, Garland J, Ondruschka B, Wong CX, et al. First identified case of fatal fulminant necrotizing eosinophilic myocarditis following the initial dose of the Pfizer-BioNTech mRNA COVID-19 vaccine (BNT162b2, Comirnaty): an extremely rare idiosyncratic hypersensitivity reaction. J Clin Immunol [Internet]. Nature Publishing Group; 2022 [cited 2022 Aug 29];42:441. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC8720536\/.","DOI":"10.1007\/s10875-021-01187-0"},{"key":"1801_CR48","doi-asserted-by":"crossref","unstructured":"Ashaari S, Sohaib HA, Bolger K. A case report: symptomatic pericarditis post-COVID-19 vaccination. Eur Hear journal Case reports [Internet]. Eur Heart J Case Rep; 2021 [cited 2022 Aug 29];5. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/34693198\/.","DOI":"10.1093\/ehjcr\/ytab375"},{"key":"1801_CR49","doi-asserted-by":"crossref","unstructured":"D\u2019Angelo T, Cattafi A, Carerj ML, Booz C, Ascenti G, Cicero G, et al. Myocarditis after SARS-CoV-2 vaccination: a vaccine-induced reaction? Can J Cardiol [Internet]. Elsevier; 2021 [cited 2022 Aug 29];37:1665. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC8187737\/.","DOI":"10.1016\/j.cjca.2021.05.010"},{"key":"1801_CR50","doi-asserted-by":"crossref","unstructured":"Marshall M, Ferguson ID, Lewis P, Jaggi P, Gagliardo C, Collins JS, et al. Symptomatic acute myocarditis in 7 adolescents after pfizer-biontech covid-19 vaccination. Pediatrics [Internet]. American Academy of Pediatrics; 2021 [cited 2022 Aug 29];148. Available from: https:\/\/publications.aap.org\/pediatrics\/article\/148\/3\/e2021052478\/179728\/Symptomatic-Acute-Myocarditis-in-7-Adolescents.","DOI":"10.1542\/peds.2021-052478"},{"key":"1801_CR51","unstructured":"Facetti S, Giraldi M, Vecchi AL, Rogiani S, Nassiacos D. [Acute myocarditis in a young adult two days after Pfizer vaccination]. G Ital Cardiol (Rome) [Internet]. G Ital Cardiol (Rome); 2021 [cited 2022 Aug 29];22:891\u20133. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/34709227\/."},{"key":"1801_CR52","doi-asserted-by":"crossref","unstructured":"King WW, Petersen MR, Matar RM, Budweg JB, Pardo LC, Petersen JW. Myocarditis following mRNA vaccination against SARS-CoV-2, a case series. Am Hear J plus [Internet]. Elsevier; 2021 [cited 2022 Aug 29];8:100042. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC8349733\/.","DOI":"10.1016\/j.ahjo.2021.100042"},{"key":"1801_CR53","doi-asserted-by":"crossref","unstructured":"Hasnie AA, Hasnie UA, Patel N, Aziz MU, Xie M, Lloyd SG, et al. Perimyocarditis following first dose of the mRNA-1273 SARS-CoV-2 (Moderna) vaccine in a healthy young male: a case report. BMC Cardiovasc Disord [Internet]. BioMed Central Ltd; 2021 [cited 2022 Aug 29];21:1\u20136. Available from: https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-021-02183-3.","DOI":"10.1186\/s12872-021-02183-3"},{"key":"1801_CR54","doi-asserted-by":"crossref","unstructured":"Patrignani A, Schicchi N, Calcagnoli F, Falchetti E, Ciampani N, Argalia G, et al. Acute myocarditis following Comirnaty vaccination in a healthy man with previous SARS-CoV-2 infection. Radiol Case Reports [Internet]. Elsevier; 2021 [cited 2022 Aug 29];16:3321. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC8326008\/.","DOI":"10.1016\/j.radcr.2021.07.082"},{"key":"1801_CR55","doi-asserted-by":"crossref","unstructured":"Howlett JG, McKelvie RS, Arnold JMO, Costigan J, Dorian P, Ducharme A, et al. Canadian Cardiovascular Society Consensus Conference guidelines on heart failure, update 2009: diagnosis and management of right-sided heart failure, myocarditis, device therapy and recent important clinical trials. Can J Cardiol [Internet]. Can J Cardiol; 2009 [cited 2022 Aug 29];25:85\u2013105. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/19214293\/.","DOI":"10.1016\/S0828-282X(09)70477-5"},{"key":"1801_CR56","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1161\/CIRCULATIONAHA.113.001531","volume":"128","author":"M Imazio","year":"2013","unstructured":"Imazio M, Brucato A, Barbieri A, Ferroni F, Maestroni S, Ligabue G, et al. Good prognosis for pericarditis with and without myocardial involvement: results from a multicenter, prospective cohort study. Circulation. 2013;128:42\u20139.","journal-title":"Circulation"},{"key":"1801_CR57","unstructured":"AHA. COVID-19 vaccine benefits still outweigh risks, despite possible rare heart complications | American Heart Association [Internet]. AHA Statement. 2021 [cited 2022 Sep 2]. Available from: https:\/\/newsroom.heart.org\/news\/covid-19-vaccine-benefits-still-outweigh-risks-despite-possible-rare-heart-complications."},{"issue":"10","key":"1801_CR58","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1016\/j.jcmg.2022.01.008","volume":"15","author":"JL Cavalcante","year":"2022","unstructured":"Cavalcante JL, Shaw KA, G\u00f6ssl M. Cardiac magnetic resonance imaging midterm follow up of COVID-19 vaccine\u2013associated myocarditis. JACC Cardiovasc Imaging. 2022;15(10):1821\u20134 S1936878X22000511. https:\/\/doi.org\/10.1016\/j.jcmg.2022.01.008.","journal-title":"JACC Cardiovasc. Imaging"},{"key":"1801_CR59","unstructured":"Moulson N, Petek BJ, Drezner JA, Harmon KG, Kliethermes SA, Patel MR, et al. SARS-CoV-2 cardiac involvement in young competitive athletes. Circulation [Internet]. Lippincott Williams & WilkinsHagerstown, MD; 2021 [cited 2022 Sep 15];144:256\u201366. Available from: https:\/\/www.ahajournals.org\/doi\/abs\/10.1161\/CIRCULATIONAHA.121.054824."},{"key":"#cr-split#-1801_CR60.1","doi-asserted-by":"crossref","unstructured":"\u2022 Gluckman TJ, Bhave NM, Allen LA, Chung EH, Spatz ES, Ammirati E, et al. 2022 ACC expert consensus decision pathway on cardiovascular sequelae of COVID-19 in adults: myocarditis and other myocardial involvement, post-acste Sequelae of SARS-CoV-2 infection, and return to play: a report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol [Internet]. Elsevier","DOI":"10.1016\/j.jacc.2022.02.003"},{"key":"#cr-split#-1801_CR60.2","unstructured":"2022 [cited 2022 Sep 15];79:1717. Available from: \/pmc\/articles\/PMC8926109\/. American College of Cardiology issued a consensus report on recommendations regarding return to play in athelets with myocarditis after COVID-19 infection. This study is a detailed expert opinion on young active patient population including athletes affected with myocarditis secondary to COVID-19 infection."},{"key":"1801_CR61","doi-asserted-by":"crossref","unstructured":"Ryan M, Montgomery J, Engler R, Hoffman D, McClenathan B, Collins L, et al. Myocarditis following immunization with mRNA COVID-19 vaccines in members of the US military. JAMA Cardiol [Internet]. American Medical Association; 2021 [cited 2022 Sep 15];6:1202\u20136. Available from: https:\/\/jamanetwork.com\/journals\/jamacardiology\/fullarticle\/2781601.","DOI":"10.1001\/jamacardio.2021.2833"},{"key":"1801_CR62","doi-asserted-by":"crossref","unstructured":"Kauth M, Kovacs RJ. Recognizing and managing myocarditis following COVID-19 vaccination: mitigating risk of sudden cardiac death in athletes. J Am Coll Cardiol [Internet]. Elsevier; 2022 [cited 2022 Sep 15];79:2397. Available from: \/pmc\/articles\/PMC8972386\/.","DOI":"10.1016\/S0735-1097(22)03388-5"},{"key":"1801_CR63","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.1016\/j.jcmg.2019.01.022","volume":"12","author":"NP Shah","year":"2019","unstructured":"Shah NP, Verma BR, Ala CK, Khayata M, Phelan D, Imazio M, et al. Exercise is good for the heart but not for the inflamed pericardium? JACC Cardiovasc Imaging. 2019;12:1880\u20131 (Elsevier Inc.).","journal-title":"JACC Cardiovasc Imaging."},{"key":"1801_CR64","doi-asserted-by":"crossref","unstructured":"Berglund F, Klein AL. Is exercise restriction necessary in patients with pericarditis? Cleve Clin J Med [Internet]. Cleveland Clinic Journal of Medicine; 2022 [cited 2022 Sep 15];89:437\u201341. Available from: https:\/\/www.ccjm.org\/content\/89\/8\/437.","DOI":"10.3949\/ccjm.89a.21120"},{"key":"#cr-split#-1801_CR65.1","doi-asserted-by":"crossref","unstructured":"Patone M, Mei XW, Handunnetthi L, Dixon S, Zaccardi F, Shankar-Hari M, et al. Risks of myocarditis, pericarditis, and cardiac arrhythmias associated with COVID-19 vaccination or SARS-CoV-2 infection. Nat Med 2021 282 [Internet]. Nature Publishing Group","DOI":"10.1038\/s41591-021-01630-0"},{"key":"#cr-split#-1801_CR65.2","unstructured":"2021 [cited 2022 Sep 15];28:410-22. Available from: https:\/\/www.nature.com\/articles\/s41591-021-01630-0."},{"key":"1801_CR66","doi-asserted-by":"crossref","unstructured":"Ammirati E, Lupi L, Palazzini M, Hendren NS, Grodin JL, Cannistraci C V., et al. Prevalence, characteristics, and outcomes of COVID-19-associated acute myocarditis. Circulation [Internet]. Circulation; 2022 [cited 2022 Sep 15];145:1123\u201339. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/35404682\/.","DOI":"10.1161\/CIRCULATIONAHA.121.056817"},{"key":"1801_CR67","unstructured":"\u2022\u2022 Chou OHI, Zhou J, Lee TTL, Kot T, Lee S, Wai AKC, et al. Comparisons of the risk of myopericarditis between COVID-19 patients and individuals receiving COVID-19 vaccines: a population-based study. Clin Res Cardiol [Internet]. Clin Res Cardiol; 2022 [cited 2022 Sep 15]; Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/35333945\/. This is an important study comparing the risk of myocarditis with COVID-19 infection and vaccination and findings from this study suggest that the rate of myocarditis after COVID-19 infection is 326 per million as compared to 5.5 per million after COVID-19 vaccination."},{"key":"1801_CR68","doi-asserted-by":"crossref","unstructured":"Brucato A, Trotta L, Arad M, Cremer PC, Gaddam E, Insalaco A, et al. Abstract 12057: Absence of pericarditis recurrence in rilonacept-treated patients with COVID-19 and mRNA vaccinations: Experience from phase 3 rhapsody long-term extension. Circulation. 2022;146:A12057. Available from: https:\/\/www.ahajournals.org\/doi\/abs\/10.1161\/circ.146.suppl_1.12057.","DOI":"10.1161\/circ.146.suppl_1.12057"},{"key":"1801_CR69","doi-asserted-by":"crossref","unstructured":"Gurdasani D, Bhatt S, Costello A, Denaxas S, Flaxman S, Greenhalgh T, et al. Vaccinating adolescents against SARS-CoV-2 in England: a risk-benefit analysis. J R Soc Med [Internet]. J R Soc Med; 2021 [cited 2022 Sep 15];114:513\u201324. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/34723680\/.","DOI":"10.1177\/01410768211052589"}],"container-title":["Current Cardiology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-022-01801-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11886-022-01801-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-022-01801-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,2]],"date-time":"2023-12-02T00:11:26Z","timestamp":1701475886000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11886-022-01801-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,28]]},"references-count":73,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1801"],"URL":"https:\/\/doi.org\/10.1007\/s11886-022-01801-6","relation":{},"ISSN":["1523-3782","1534-3170"],"issn-type":[{"value":"1523-3782","type":"print"},{"value":"1534-3170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,28]]},"assertion":[{"value":"7 October 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr. Klein has received a research grant from and is a scientific advisory board member for Kiniksa Pharmaceuticals; and is a scientific advisory board member for Swedish Orphan Biovitrum, Sweden, Pfizer, USA, and Cardiol Therapeutics; and he has a leadership or fiduciary role on the National Board of Echocardiography. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}